Search for: "Kerr Drug, Inc." Results 21 - 40 of 48
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Sep 2010, 8:52 pm by Steve Kalar
Comprehensive Drug Testing, Inc., 2010 WL 352947 (9th Cir. [read post]
30 Mar 2011, 6:27 am by Adam Chandler
In the second case decided yesterday, Astra USA, Inc. v. [read post]
19 Jul 2007, 1:47 pm
Kerr Corp., 418 F.3d 583, 591 (6th Cir. 2005) (OTC product) (applying Tennessee law); Ackley v. [read post]
17 May 2011, 7:20 am by Nabiha Syed
Jeppesen Dataplan, Inc., also known as the “extraordinary rendition” case, garnered significant coverage. [read post]
22 May 2011, 12:00 pm by Blog Editorial
The case of E (Children) will be heard in Courtroom 2 by Lord Hope, Lord Walker, Lady Hale, Lord Kerr and Sir Nicholas Wilson. [read post]
6 Jul 2012, 7:12 am by Rachel Sachs
John Wiley & Sons, Inc. [read post]
27 Mar 2014, 1:29 am
I have posted the opinion here: In the Matter of the Search of Information Associated with [redacted]@mac.com that is Stored at Premises Controlled by Apple, Inc. [read post]
26 Aug 2009, 7:48 am
Major League Baseball, Inc. cut a deal with the player's union to provide for suspicionless, random, anonymous drug testing. [read post]
26 Aug 2009, 7:48 am
Major League Baseball, Inc. cut a deal with the player's union to provide for suspicionless, random, anonymous drug testing. [read post]
15 Jul 2010, 2:39 pm by Bexis
Ark. 2009), a case involving multiple producers of the same drug in branded and generic forms. [read post]
21 Jun 2012, 7:40 am by Bexis
Kerr-McGee Chemical Corp., 37 F.3d 96, 101 (3d Cir. 1994); City of Philadelphia v. [read post]
7 Jul 2011, 2:31 pm by Bexis
March 28, 1997) (reaffirming PTO 12 in light of Medtronic, Inc. v. [read post]
11 Apr 2011, 6:29 am by Keith Lee
Comprehensive Drug Testing, Inc., 621 F.3d 1162, 1176 (9th Cir. 2010) (en banc). [read post]
7 Jan 2015, 10:52 am by Maureen Johnston
Kerr 14-460Issue: (1) Whether, after this Court's decision in New York v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
16 Sep 2010, 1:22 pm by Bexis
Kerr-McGee Chemical Corp., 37 F.3d 96 (3d Cir. 1994), the court refused to expand New Jersey’s “product line” exception to corporate transactions not involving the specific product line. [read post]